Journal Article

Letter to the editor: switching treatment to lamivudine plus boosted atazanavir or darunavir in virologically suppressed HIV-infected patients – evidence from a large observational cohort

D. F. Bavaro; D. Di Carlo; P. Zuccalà; F. Bai; F. Incardona; A. Battisti; S. Giachè; E. Salomoni; R. Gagliardini; S. Di Giambenedetto; M. Pecorari; M. Zazzi; A. De Luca; A. Bezenchek; S. Lo Caputo

Infectious Diseases · Vol. 51, Issue 3 · pp. 234-239 · 2019

View Full Text Download RIS Journal Homepage

Abstract

Abstract is unavailable.

Bibliographic Information

Journal	Infectious Diseases
Publisher	Taylor & Francis
Publication Date	2019-03-04
Publication Year	2019
Volume	51
Issue	3
Pages	234-239
Document Type	Journal Article
Print ISSN	2374-4235
eISSN	2374-4243
DOI	10.1080/23744235.2018.1544423

Access Information

NARA Access Coverage	2015-01-02~Current
Journal Homepage	https://www.tandfonline.com/journals/infd20
Publisher Page	Open Publisher Page

Full-text access depends on NARA's subscribed coverage and institutional access.